Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000899923-25-000064
Filing Date
2025-06-05
Accepted
2025-06-05 16:17:27
Documents
17
Effectiveness Date
2025-06-05

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8mygn_june2025.htm S-8 69196
2 ex-107filingfeesjune2025.htm   iXBRL EX-FILING FEES 12859
3 EX-5.1 ex-51mintzopinionjun25.htm EX-5.1 13069
4 EX-23.1 ex-231consent_june2025.htm EX-23.1 2201
5 EX-99.1 ex2017employeedirectorcons.htm EX-99.1 85215
6 image_1a.jpg GRAPHIC 7104
7 imagea.jpg GRAPHIC 14785
  Complete submission text file 0000899923-25-000064.txt   330223

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT ex-107filingfeesjune2025_htm.xml XML 4871
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287804 | Film No.: 251027325
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)